Sangamo Therapeutics
SGMO
#8725
Rank
C$0.23 B
Marketcap
C$0.69
Share price
-6.45%
Change (1 day)
-75.20%
Change (1 year)

Sangamo Therapeutics (SGMO) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : C$0.11 Billion

According to Sangamo Therapeutics 's latest financial reports the company's total liabilities are C$0.11 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Sangamo Therapeutics - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31C$0.11 B3.51%
2023-12-31C$0.10 B-69.88%
2022-12-31C$0.36 B-17.8%
2021-12-31C$0.44 B-21.48%
2020-12-31C$0.56 B110.33%
2019-12-31C$0.26 B-12.01%
2018-12-31C$0.30 B144.6%
2017-12-31C$0.12 B326.21%
2016-12-31C$29.15 M-15.24%
2015-12-31C$34.39 M-18.97%
2014-12-31C$42.44 M108.48%
2013-12-31C$20.36 M16.1%
2012-12-31C$17.53 M139.33%
2011-12-31C$7.32 M3.37%
2010-12-31C$7.08 M-56.97%
2009-12-31C$16.47 M8.79%
2008-12-31C$15.14 M28.88%
2007-12-31C$11.74 M42.64%
2006-12-31C$8.23 M-36.65%
2005-12-31C$13 M361.09%
2004-12-31C$2.82 M38.39%
2003-12-31C$2.03 M-34.87%
2002-12-31C$3.12 M-26.39%
2001-12-31C$4.25 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Gilead Sciences
GILD
C$51.22 B 44,896.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
C$6.37 B 5,504.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$111.24 B 97,620.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$15.19 B 13,249.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
C$57.92 B 50,781.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$156.85 B 137,690.05%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$2.15 B 1,790.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$107.25 B 94,122.09%๐Ÿ‡บ๐Ÿ‡ธ USA